ClinicalTrials.Veeva

Menu

Bowditch Revisited: Defining the Optimum Heart Rate Range in Chronic Heart Failure

U

University of Leeds

Status

Unknown

Conditions

Chronic Heart Failure

Treatments

Device: Tailored pacemaker settings

Study type

Interventional

Funder types

Other

Identifiers

NCT02563873
12/YH/0097

Details and patient eligibility

About

The investigators are examining the relationship between heart rate and heart contraction in patients with heart failure and pacemakers, aiming to improve quality of life.

Full description

Heart rate lowering is a cornerstone of the management of chronic heart failure (CHF) and the degree of lowering is closely related to improvements in longevity, hospitalisation rate and heart function. The investigators have shown that increasing heart rates using pacemakers does not increase exercise capacity in CHF patients. This might be because the optimal heart rate range for contraction is narrower for patients with CHF. At higher heart rates, heart contraction might be less strong. The investigators now want to examine the relationship between heart rate and heart contraction in patients with heart failure and pacemakers. Tailored pacemaker heart rate setting's, individually optimised for heart contractility as assessed by cardiac ultrasound, will be investigated to examine the effects on exercise tolerance .

Enrollment

110 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • stable CHF
  • Cardiac Resynchronisation Therapy (CRT) device for >3 months,
  • able to walk on treadmill

Exclusion criteria

  • unable to walk on treadmill,
  • unstable angina pectoris
  • uncontrolled heart rate
  • prescribed calcium channel blocker
  • significant aortic stenosis
  • significant airways disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

110 participants in 2 patient groups

Standard pacemaker settings
No Intervention group
Description:
Standard pacemaker settings will be programmed and the patient will complete a symptom limited exercise tolerance test with metabolic gas exchange
Tailored pacemaker settings
Experimental group
Description:
The pacemaker settings will be altered to match optimal heart rate range with respect to cardiac contractility, as determined by echocardiography. This will be programmed and the patient will complete a symptom limited exercise tolerance test with metabolic gas exchange.
Treatment:
Device: Tailored pacemaker settings

Trial contacts and locations

1

Loading...

Central trial contact

John Gierula, BSc; Klaus K Witte, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems